Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Triwira Insanlestari Tbk. (TRIL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Triwira Insanlestari Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Triwira Insanlestari Tbk. trades at Rp50 (market cap 60B). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.8× Triwira Insanlestari Tbk.'s market cap. Which is the better fit depends on your goals.
| OBAT | TRIL | |
|---|---|---|
Market Cap | 166.01B | 60B |
Volume | 324K | — |
Lot | 3.24K | — |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Triwira Insanlestari Tbk.
PT Triwira Insanlestari Tbk (the company) was established on 26 Oct 1992 based on Notaries Deed No. 185 of Erny Tjandrasasmita, S.H.The Companys articles of association has been amended several times, most recently by notarial deed No. 6 of Lenny Janis Ishak, S.H., dated Sep 17, 2007, concerning among others, the change company's name, par value and public offering.
Read more on TRIL →
